[1] Taylor CJ, Ordóñez-Mena JM, Roalfe AK, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ, 2019; 364, l223.
[2] Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart, 2007; 93, 1137−46. doi:  10.1136/hrt.2003.025270
[3] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail, 2016; 18, 891−975.
[4] McMurray MD, Trivax JE, McCullough PA. Serum cystatin C, renal filtration function, and left ventricular remodeling. Circ Heart Fail, 2009; 2, 86−9. doi:  10.1161/CIRCHEARTFAILURE.109.856393
[5] Correale M, Monaco I, Brunetti ND, et al. Redefining biomarkers in heart failure. Heart Fail Rev, 2018; 23, 237−53. doi:  10.1007/s10741-018-9683-2
[6] Li X, Zhu H, Li P, et al. Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy. J Geriatr Cardiol, 2013; 10, 286−90.
[7] Dupont M, Wu YP, Hazen SL, et al. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events. Circ Heart Fail, 2012; 5, 602−9. doi:  10.1161/CIRCHEARTFAILURE.112.966960
[8] Maia AL, Goemann IM, Meyer ELS, et al. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J Endocrinol, 2011; 209, 283−97. doi:  10.1530/JOE-10-0481
[9] Okayama D, Minami Y, Kataoka S, et al. Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure. J Cardiol, 2015; 66, 205−11. doi:  10.1016/j.jjcc.2015.04.006
[10] van der Molen AJ, Thomsen HS, Morcos SK. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol, 2004; 14, 902−7. doi:  10.1007/s00330-004-2238-z